Corporate News
Page 10
Nov 22, 2010
Reinnervate launches Alvetex®, a breakthrough product for enabling routine 3D cell culture
Reinnervate, is very pleased to announce today the first commercial launch of Alvetex®, its breakthrough 3D cell culture technology. find out more.
Nov 17, 2010
Reinnervate completes expansion into new purpose-built facility at NETPark
Reinnervate, an innovative life sciences company driving the adoption of routine 3D cell culture, today announced its expansion into a new purpose-built research and production facility at NETPark near Sedgefield, UK.
Sep 28, 2010
Reinnervate’s ec23® shown to enhance neuronal differentiation of human fetal neuroprogenitors and human embryonic stem cells
Read more about Reinnervate’s ec23 and its ability to enhance neuronal differentiation as demonstrated in a paper published in Neuroscience Methods.
Sep 28, 2010
Reinnervate wins Chemistry Innovation / EPSRC Industrial CASE Award to fund development of Alvetex® for the 3D culture of liver cells
Reinnervate has been granted a Chemistry Innovation Knowledge Transfer Network / EPSRC Industrial CASE Award to fund the development of a next-generation Alvetex® scaffold optimised for 3D hepatocyte culture.
Sep 14, 2010
Reinnervate has been accepted as a new member of the In Vitro Testing Industrial Platform (IVTIP)
Reinnervate has been accepted into the In Vitro Testing Industrial Platform, advising European bodies on research projects in in vitro testing.
May 27, 2010
Reinnervate secures £1.8 million of investment to support commercialisation of Alvetex
Reinnervate has successfully raised £1.8 million in new equity funding to complete the development of its Alvetex® 3D cell culture platform.